SEC Form 4 · accession 0001493152-26-029122
Apyx Medical Corp · APYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shawn David Roman
Officer — Chief Operating Officer
Period of report
Jun 15, 2026
Accepted (ET)
Jun 17, 2026 · 5:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000719135
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 15, 2026 | M | 15,000 | $3.23 | A | 15,000 | I | By The Roman Family Revocable Trust |
| Common StockF1 | Jun 15, 2026 | F | 10,533 | $4.60 | D | 16,467 | I | By The Roman Family Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F2 | $3.23 | Jun 15, 2026 | M | 15,000 | D | — | May 1, 2027 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary.
- F2On June 15, 2026, the Reporting Person effected a net exercise of 15,000 stock options with an exercise price of $3.23 per share. Pursuant to the terms of the exercise, 10,533 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.60 per share to satisfy the aggregate exercise price, resulting in the issuance of 4,467 net shares to the Reporting Person.